Hosted on MSN1mon
MDCX: Medicus Pharma 3Q 2024 Financial Results Reported; Stock Now Trades Both in Canada and on Nasdaq After Completing an IPO in the U.S.
On November 22, 2024, Medicus Pharma (NASDAQ:MDCX) (TSXV:MDCX) reported financial results for the third quarter ending September 30, 2024. Still being in the clinical trial stage, the company did ...
Hosted on MSN22d
Medicus Pharma initiated at buy by Brookline Capital
Brookline Capital Markets initiated coverage of Medicus Pharma (NASDAQ:MDCX) with a buy rating, citing the potential of its basal cell carcinoma treatment D-MNA. The investment firm noted that D ...
Nasdaq1mon
Medicus Pharma Ltd. Receives FDA MUMS Designation for Doxorubin Microneedle Array to Treat Squamous Cell Carcinoma in Horses
Medicus Pharma Ltd. has announced that its Investigational New Animal Drug for a dissolvable Doxorubicin-containing microneedle array (D-MNA) has received Minor Use in Major Species Designation ...
Yahoo Finance1mon
Medicus Pharma Ltd. (MDCX.V)
Company to Submit Product Development Plan to Treat External Squamous Cell Carcinoma (SCC) in HorsesTORONTO and PHILADELPHIA, Dec. 12, 2024 (GLOBE NEWSWIRE) -- Medicus Pharma Ltd. (NASDAQ ...
Business Insider1mon
Medicus Pharma Ltd. Announces Minor Use (MUMS) Designation from the FDA for Doxorubicin-Containing Microneedle Array (D-MNA) Patch
TORONTO and PHILADELPHIA, Dec. 12, 2024 (GLOBE NEWSWIRE) -- Medicus Pharma Ltd. (NASDAQ: MDCX) (TSXV: MDCX) ("Medicus" or the "Company") is pleased to announce that its Investigational New Animal ...
2024 in Review: Bucking trend, these Philadelphia-area life sciences companies raised nearly $1B
Bucking the trend, a number of Philadelphia-area life sciences companies raised more than $100 million in private equity ...
Business Insider22d
Medicus Pharma Ltd: Innovative D-MNA Product Positions Company for Success with Favorable Buy Rating
Medicus Pharma Ltd (MDCX) has received a new Buy rating, initiated by Brookline Capital Markets analyst, Kumaraguru Raja. Discover the latest stocks recommended by top Wall Street analysts ...
Seeking Alpha12d
Medicus Pharma Ltd. WT EXP 111529
CHEB.WSChenghe Acquisition II Co. Chenghe Acquisition II Co. SBXD.WSSilverBox Corp IV WT EXP 081929 SilverBox Corp IV WT EXP 081929 AAM.WSAA Mission Acquisition Corp. WT EXP 080131 AA Mission ...
London South East7d
Medicus Pharma Ltd Share Price (MDCXW.US)
Medicus Pharma Ltd is listed on the CBOE trading with ticker code MDCXW.US. It has a market capitalisation of -, with approximately 0.00 shares in issue. Over the last year, Medicus Pharma Ltd ...
Nasdaq22d
Medicus Pharma initiated with a Buy at Brookline
Brookline analyst Kumaraguru Raja initiated coverage of Medicus Pharma (MDCX) with a Buy rating and $12 price target Medicus is advancing D-MNA, a doxorubicin tip loaded dissolvable microarray ...
Morningstar6d
Medicus Pharma Ltd MDCX
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...